Levy BP - Search Results

1

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR. Levy BP, et al. Oncologist. 2015 Oct;20(10):1175-81. doi: 10.1634/theoncologist.2015-0114. Epub 2015 Sep 1. Oncologist. 2015. PMID: 26330460 Free PMC article.

2

Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.

Levy B, Hu ZI, Cordova KN, Close S, Lee K, Becker D. Levy B, et al. Oncologist. 2016 Sep;21(9):1121-30. doi: 10.1634/theoncologist.2016-0082. Epub 2016 Jul 7. Oncologist. 2016. PMID: 27388233 Free PMC article. Review.

3

Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.

McMullen S, Hess LM, Kim ES, Levy B, Mohamed M, Waterhouse D, Wozniak A, Goring S, Müller K, Muehlenbein C, Aggarwal H, Zhu Y, Oton AB, Ersek JL, Winfree KB. McMullen S, et al. Patient. 2019 Apr;12(2):223-233. doi: 10.1007/s40271-018-0327-3. Patient. 2019. PMID: 30128728 Free PMC article.

4

Therapeutic Effects of Repurposed Therapies in Non-Small Cell Lung Cancer: What Is Old Is New Again.

Saxena A, Becker D, Preeshagul I, Lee K, Katz E, Levy B. Saxena A, et al. Oncologist. 2015 Aug;20(8):934-45. doi: 10.1634/theoncologist.2015-0064. Epub 2015 Jul 8. Oncologist. 2015. PMID: 26156329 Free PMC article. Review.

5

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung Cancer.

Ahluwalia MS, Becker K, Levy BP. Ahluwalia MS, et al. Among authors: levy bp. Oncologist. 2018 Oct;23(10):1199-1209. doi: 10.1634/theoncologist.2017-0572. Epub 2018 Apr 12. Oncologist. 2018. PMID: 29650684 Free PMC article. Review.

6

Extended-duration therapy in advanced non-small-cell lung cancer: promise and pitfalls.

Levy B, Drilon A, Siu K, Grossbard M. Levy B, et al. Clin Lung Cancer. 2010 Nov 1;11(6):383-90. doi: 10.3816/CLC.2010.n.050. Clin Lung Cancer. 2010. PMID: 21062729

7

A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancer.

Levy B, Spira A, Becker D, Evans T, Schnadig I, Camidge DR, Bauman JE, Hausman D, Walker L, Nemunaitis J, Rudin CM, Halmos B, Bowles DW. Levy B, et al. J Thorac Oncol. 2014 Jul;9(7):1031-1035. doi: 10.1097/JTO.0000000000000183. J Thorac Oncol. 2014. PMID: 24926548 Free article. Clinical Trial.

8

Systemic therapy for small cell lung cancer.

Levy B, Saxena A, Schneider BJ. Levy B, et al. J Natl Compr Canc Netw. 2013 Jul;11(7):780-7. doi: 10.6004/jnccn.2013.0100. J Natl Compr Canc Netw. 2013. PMID: 23847216 Review.

9

A pooled analysis of two phase II trials evaluating metformin plus platinum-based chemotherapy in advanced non-small cell lung cancer.

Parikh AB, Marrone KA, Becker DJ, Brahmer JR, Ettinger DS, Levy BP. Parikh AB, et al. Among authors: levy bp. Cancer Treat Res Commun. 2019;20:100150. doi: 10.1016/j.ctarc.2019.100150. Epub 2019 May 10. Cancer Treat Res Commun. 2019. PMID: 31102920 Clinical Trial.

10

Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.

Schneider BJ, Ismaila N, Aerts J, Chiles C, Daly ME, Detterbeck FC, Hearn JWD, Katz SI, Leighl NB, Levy B, Meyers B, Murgu S, Nekhlyudov L, Santos ES, Singh N, Tashbar J, Yankelevitz D, Altorki N. Schneider BJ, et al. J Clin Oncol. 2020 Mar 1;38(7):753-766. doi: 10.1200/JCO.19.02748. Epub 2019 Dec 12. J Clin Oncol. 2020. PMID: 31829901

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters